[email protected] (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Pruritus Therapeutics Market by Drug type (Corticosteroids, Antihistamines, Local Anesthetics, Immunosuppressant, Others), by Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Others), by Distribution Channel (Hospital Pharmacies, Drug stores & Retail Pharmacies, Online providers): Global Opportunity Analysis and Industry Forecast, 2022-2030

Pruritus Therapeutics Market by Drug type (Corticosteroids, Antihistamines, Local Anesthetics,...

Home / Categories / Healthcare
Pruritus Therapeutics Market by Drug type (Corticosteroids, Antihistamines, Local Anesthetics, Immunosuppressant, Others), by Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Others), by Distribution Channel (Hospital Pharmacies, Drug stores & Retail Pharmacies, Online providers): Global Opportunity Analysis and Industry Forecast, 2022-2030
Pruritus Therapeutics Market by Drug...
Report Code
RO1/128/1012

Publish Date
24/Mar/2023

Pages
200
PRICE
$ 4900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5400/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8700/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

The global pruritus therapeutics market size was US$ 7.9 billion in 2021. The global pruritus therapeutics market size is estimated to reach US$ 10.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.6% during the forecast period from 2022 to 2030.
Pruritus therapeutics are medicines utilized in the therapy of pruritus disorder. It is the itching caused to the skin owing to different factors like allergies, dry skin, and other conditions. A more important underlying reason is generally indicated when pruritus lasts for more time. A heightened inflammatory reaction to different possible irritants, like environmental pollutants, dust, animals, and specific foods, can cause eczema, also called atopic dermatitis. Typical products that cause contact dermatitides such as soaps, watches, garments, and jewelry produced with potentially irritating substances.

Factors Influencing Market Growth

• The leading market players which are particularly investing in research and development to create innovative pruritus therapies drive the overall market expansion.
• The lack of knowledge concerning the cause of the illness hampers the overall market expansion.
• The patent expiry of various pruritus therapeutic products provides a greater pruritus therapeutics market opportunity for players to grow their businesses. Thus, driving the overall market growth.

Effect of the COVID-19 Pandemic

COVID-19 is expected to have a minimal impact on the market. COVID-19 continues to change the various businesses develop, although its rapid effects are not all the same. While some industries will see a decline in need, many others continue to be unaffected and deliver bright prospects for growth.

Regional Analysis

North America had a major share of the market in the year 2021, due to the existence of key players, an increase in government initiatives, a well-developed healthcare infrastructure, and a rise in the majority of skin-related health problems.

Asia-Pacific is anticipated to notice the highest growth rate for the pruritus therapeutics market during the analysis period. A rise in R&D acquisitions, an increase in awareness of more recent therapies, and an increase in customer choices toward over-the-counter products are prime elements that drive the overall market expansion in the region.

Leading Competitors
The prominent players in the global pruritus therapeutics market are:
• Trevi therapeutics
• Regeneron Pharmaceuticals
• Pfizer Inc
• Evelo Biosciences
• Galderma
• LEO Pharma
• Bausch Health Companies
• Amgen 
• Cara Therapeutics
• Others
Segmentation Analysis
The global pruritus therapeutics market segmentation focuses on Drug Type, Disease Type, Distribution Channel, and Region.
Segmentation on the basis of Drug Type
• Corticosteroids
• Antihistamines
• Local Anesthetics
• Immunosuppressant
• Others

Segmentation on the basis of Disease Type
• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Others

Segmentation on the basis of Distribution Channel
• Hospital Pharmacies
• Drug stores & Retail Pharmacies
• Route of Administration
• Oral
• Parenteral
• Topical
• Online providers
Segmentation on the basis of Region
• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539